ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014

JRB Wins $3.6 Million Support contract

November 29, 1974

American Legacy Foundation Says Group is Fighting For Its Survival.

January 7, 2005

CCOPs Payline Set In Low 220s Fr Now; 45 To Be Funded

May 15, 1987

No Diet, Nutrition, Chemoprevention Concepts Due For DRCCA Board In October, But Maybe In January

July 29, 1983

NCI-Approved Clinical Trials

July 30, 2004